Walleye Capital LLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 1758720 NEW YORK, NY

Position in PMVP

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$449,829

+$33,569 QoQ

Shares Held

335,694

0.0% QoQ

Ownership

0.628%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 64 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. PMVP ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	126,005	$33,608,053
2	CYTK	Cytokinetics Inc	239,728	$20,422,428
3	BMRN	Biomarin Pharmaceutical Inc	288,233	$16,492,692
4	IDYA	IDEAYA Biosciences, Inc.	386,183	$14,393,040
5	REGN	Regeneron Pharmaceuticals, Inc.	22,596	$14,089,509
6	RARE	Ultragenyx Pharmaceutical Inc.	334,854	$11,180,775
7	TYRA	Tyra Biosciences, Inc.	347,898	$11,111,862
8	BCAX	Bicara Therapeutics Inc.	353,226	$10,487,279

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$449,829	335,694	0.0%	Shares	Sole	2026-08-03
2026-03-31	$416,260	335,694	0.0%	Shares	Sole	2026-05-13
2025-12-31	$419,617	335,694	+20.6%	Shares	Sole	2026-02-13
2025-09-30	$389,842	278,459	+257.5%	Shares	Sole	2025-11-14
2025-06-30	$82,560	77,887	-23.4%	Shares	Sole	2025-08-13
2025-03-31	$110,848	101,696	-20.3%	Shares	Sole	2025-05-14
2024-12-31	$192,715	127,626	-12.4%	Shares	Sole	2025-02-13
2024-09-30	$217,148	145,737	0.0%	Shares	Sole	2024-11-14
2024-06-30	$236,093	145,737	+187.6%	Shares	Sole	2024-08-14
2024-03-31	$86,130	50,665	+0.5%	Shares	Sole	2024-05-15
2023-12-31	$156,233	50,398	+339.4%	Shares	Sole	2024-02-14
2023-06-30	$71,808	11,471	-79.5%	Shares	Sole	2023-08-14
2023-03-31	$266,848	55,943	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.